|
RC3H2 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.17159623616681E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.27609955724984E-10 |
| Normal-vs-Stage2 |
2.31310000042839E-07 |
| Normal-vs-Stage3 |
2.93719493171807E-11 |
| Normal-vs-Stage4 |
1.88630222552888E-11 |
| Stage1-vs-Stage2 |
6.481200E-01 |
| Stage1-vs-Stage3 |
1.575390E-01 |
| Stage1-vs-Stage4 |
1.754390E-02 |
| Stage2-vs-Stage3 |
5.794600E-01 |
| Stage2-vs-Stage4 |
1.963780E-01 |
| Stage3-vs-Stage4 |
3.801400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.18000062446322E-11 |
| Normal-vs-AfricanAmerican |
1.197510E-03 |
| Normal-vs-Asian |
5.67919999916455E-09 |
| Caucasian-vs-AfricanAmerican |
3.273400E-01 |
| Caucasian-vs-Asian |
3.291400E-01 |
| AfricanAmerican-vs-Asian |
1.264020E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.67643676718399E-14 |
| Normal-vs-Female |
9.93409798866196E-11 |
| Male-vs-Female |
2.884400E-02 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.43170000194348E-08 |
| Normal-vs-Age(41-60Yrs) |
8.00881583273849E-12 |
| Normal-vs-Age(61-80Yrs) |
3.52773366074643E-12 |
| Normal-vs-Age(81-100Yrs) |
5.553900E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.014360E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.123700E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.002200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.248800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.784600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.712800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.221650E-01 |
| Classical-VS-Follicular |
4.488000E-02 |
| Classical-VS-Other |
1.127830E-01 |
| Classical-VS-Normal |
4.15820045063242E-10 |
| Tall-VS-Follicular |
8.279000E-01 |
| Tall-VS-Other |
3.421600E-01 |
| Tall-VS-Normal |
3.35909999815698E-08 |
| Follicular-VS-Other |
3.693400E-01 |
| Follicular-VS-Normal |
1.27799992810651E-10 |
| Other-VS-Normal |
1.166870E-04 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.28372876165395E-13 |
| Normal-vs-N1 |
3.13189999490149E-08 |
| N0-vs-N1 |
8.215600E-01 |
|
|
